Fine Organic Industries Q3 Results Review: Dolat Capital Retains 'Buy', Lowers Target Price — Here's Why

Dolat Capital trims its EPS estimates by 5-6% for FY25-27E to factor time-lag in pass through of higher input costs but reiterate ‘Buy’ rating with revised target price of Rs 5500

Fine Organics' capex of Rs 7.5 billion provides much-needed growth visibility beyond FY27E. (Photo Source: freepik)

Fine Organic is operating at optimal utilizations with limited volume growth headroom till new capex comes onstream; although Patalganga facility (E73; 10ktpa) is still operating at low utilizations (to be absorbed over next couple of years).

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 

Dolat Capital Report

Fine Organic Industries Ltd.’s Q3 FY25 revenue of Rs 5.1 billion was in line with our estimates, however, Ebitda/PAT at Rs 990 million/ 827 million came below due to higher input costs and opex. Ebitda margin at 19.3% (-492 bps YoY/ -599 bps QoQ) was the lowest in the last 12 quarters.

Capex of Rs 7.5 billion provides much-needed growth visibility beyond FY27E. This expansion will largely be self-funded (~Rs 11 billion cash on books). Resumption of operations at the Badlapur facility in Q3 FY25 (disrupted since Q4 FY24, by fire at adjacent plant) to aid volumes. Management is also evaluating greenfield capex in USA.

Fine Organic is operating at optimal utilizations with limited volume growth headroom till new capex comes onstream; although Patalganga facility (E73; 10ktpa) is still operating at low utilizations (to be absorbed over next couple of years).

We trim our EPS estimates by 5-6% for FY25-27E to factor time-lag in pass through of higher input costs but reiterate ‘Buy’ rating with revised target price of Rs 5500 (earlier Rs 6100; 33x FY27E EPS).

Click on the attachment to read the full report:

Dolat Capital Fine Organic Q3FY25 Results Review.pdf
Read Document

Also Read: Deepak Nitrite Q3 Results Review — Headwinds Persist, Says Systematix, Maintains 'Hold' Rating On The Stock

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story You must be an existing Premium User
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google